ZyCov-D Current Affairs, GK & News

Precautionary vaccine jabs in India

The Government of India is to provide third dose of vaccine. This third dose has been named “precaution dose” or booster dose. About the precaution dose The health care workers, comorbid patients (people with severe medical conditions) and frontline workers are eligible to get the precaution dose. Five states in the country are to go ..

Month: 

Category: 

Topics: 

Three – dose ZyCov – D to be launched in seven states

ZyCov – D is the second indigenous vaccine next to COVAXIN. The unique feature of ZyCov – D is that it is needle – less vaccine. At first, the ZyCov – D vaccine is to be launched in seven states. They are Tamil Nadu, Bihar, Maharashtra, Jharkhand, Punjab, West Bengal and Uttar Pradesh. About ZyCov ..

Month: 

Category: 

Topics: 

DCGI approves ZyCoV-D vaccine for Emergency Use Authorization

The Drug Controller General of India (DGCI) has approved ZyCoV-D vaccine by Zydus Cadila for Emergency Use Authorization. Key Points According to Ministry of Science and Technology, ZyCoV-D vaccine is the world’s first and India’s indigenously developed DNA-based vaccine for COVID-19. It will be administered to humans including children and adults aged 12 years and ..

Month: 

Category: 

Topics: 

Zydus Cadila’s needle-free Covid-19 vaccine to get approval

India is to get its sixth Covid-19 vaccine soon as drug firm Zydus Cadila’s needle-free Covid-19 vaccine called ‘ZyCoV-D’ is all set to get emergency use authorisation (EUA) approval. Key Points Presently, Indian government has authorised five vaccines for Covid-19 namely, Covaxin, Covishield, Sputnik V, Moderna’s vaccine, and J&J’s single-dose vaccine. Zydus Cadila applied for ..

Month: 

Category: 

Topics: 

ZyCoV-D: World’s first DNA-based Vaccine

Indian pharmaceutical company Zydus Cadila is soon going to apply Central Drugs Regulator (DGCI) for emergency approval of the corona vaccine ZyCoV-D. If approved, it will be the world’s first DNA-based vaccine. With this, the number of vaccines available in the country will increase to 4. So far, Serum Institute’s Covishield, Bharat Biotech’s Covaxin and ..

Month: 

Category: 

Topics: 

Zydus drug Virafin gets DCGI nod

The Drug Controller General of India recently provided “Restricted Emergency Use Approval” for the use of “Virafin”. Virafin is used to treat Hepatitis B and C. Now it is to be used to treat moderate COVID-19 infections. About Virafin A single dose of Virafin during the early stage of infection, will help COVID-19 patients recover ..

Month: 

Category: 

Topics: